Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer
Globe Newswire13-11-2024, 22:57
Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2025 Financial Results on April 9, 2025 After Market Close and Host Conference Call April 10, 2025 at 10:30AM ET 7-03-2025, 04:30
